Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Director John Anthony Lederer purchased 20,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 26th. The stock was bought at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the transaction, the director now directly owns 50,000 shares in the company, valued at $3,350,000. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at $70.99 on Friday. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $70,204.04, a P/E ratio of 13.64, a PEG ratio of 1.24 and a beta of 1.20. Walgreens Boots Alliance, Inc. has a 12 month low of $63.82 and a 12 month high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.10. The business had revenue of $30.15 billion for the quarter, compared to analysts’ expectations of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The business’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.07 EPS. research analysts forecast that Walgreens Boots Alliance, Inc. will post 5.55 earnings per share for the current fiscal year.
Walgreens Boots Alliance announced that its board has initiated a stock repurchase plan on Wednesday, October 25th that allows the company to buyback $1.00 billion in shares. This buyback authorization allows the pharmacy operator to repurchase shares of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s leadership believes its stock is undervalued.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 annualized dividend and a yield of 2.25%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 42.33%.
TRADEMARK VIOLATION WARNING: “Walgreens Boots Alliance, Inc. (WBA) Director John Anthony Lederer Purchases 20,000 Shares” was first published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://stocknewstimes.com/2017/11/11/insider-buying-walgreens-boots-alliance-inc-wba-director-acquires-1340000-00-in-stock.html.
A number of hedge funds and other institutional investors have recently bought and sold shares of WBA. Commonwealth Bank of Australia raised its stake in shares of Walgreens Boots Alliance by 139.5% during the second quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock valued at $3,614,000 after acquiring an additional 26,893 shares during the last quarter. IBM Retirement Fund raised its stake in shares of Walgreens Boots Alliance by 88.1% during the second quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock valued at $2,004,000 after acquiring an additional 10,729 shares during the last quarter. Andra AP fonden raised its stake in shares of Walgreens Boots Alliance by 35.3% during the second quarter. Andra AP fonden now owns 58,300 shares of the pharmacy operator’s stock valued at $4,565,000 after acquiring an additional 15,200 shares during the last quarter. Schwab Charles Investment Management Inc. raised its stake in shares of Walgreens Boots Alliance by 5.4% during the second quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock valued at $236,476,000 after acquiring an additional 154,995 shares during the last quarter. Finally, Birinyi Associates Inc. raised its stake in Walgreens Boots Alliance by 9.0% in the second quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock worth $713,000 after buying an additional 750 shares in the last quarter. Institutional investors and hedge funds own 63.79% of the company’s stock.
A number of research firms have issued reports on WBA. Needham & Company LLC set a $94.00 price target on Walgreens Boots Alliance and gave the company a “buy” rating in a research note on Monday, July 17th. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Friday. Loop Capital set a $90.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Thursday, October 26th. Royal Bank Of Canada initiated coverage on Walgreens Boots Alliance in a report on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 price objective for the company. Finally, Robert W. Baird reiterated an “outperform” rating and issued a $80.00 price objective (down previously from $90.00) on shares of Walgreens Boots Alliance in a report on Thursday, October 19th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have given a buy rating to the company’s stock. Walgreens Boots Alliance has a consensus rating of “Buy” and an average price target of $87.63.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.